Long-term safety and absorption assessment of a novel bioresorbable nitrided iron scaffold in porcine coronary artery

被引:32
作者
Zheng, Jian-Feng [1 ]
Xi, Zi-Wei [1 ]
Li, Yang [1 ]
Li, Jia-Nan [7 ]
Qiu, Hong [1 ]
Hu, Xiao-Ying [1 ]
Luo, Tong [1 ]
Wu, Chao [1 ]
Wang, Xin [2 ]
Song, Lai-Feng [3 ]
Li, Li [3 ]
Qi, Hai-Ping [4 ]
Zhang, Gui [4 ]
Qin, Li [4 ]
Zhang, Wan-Qian [4 ]
Shi, Xiao-Li [5 ]
Wang, Shu-Han [6 ]
Zhang, De-Yuan [4 ]
Xu, Bo [1 ]
Gao, Run-Lin [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Dept Cardiol, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Beijing Key Lab Preclin Res & Evaluat Cardiovasc, Natl Ctr Cardiovasc Dis,Anim Expt Ctr, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Dept Pathol, Beijing, Peoples R China
[4] Biotyx Med Shenzhen Co Ltd, R&D Ctr, Shenzhen, Peoples R China
[5] Lifetech Sci Shenzhen Co Ltd, Natl & Local Joint Engn Lab Intervent Med Biotech, Shenzhen, Peoples R China
[6] Shen Zhen Testing Ctr Med Devices, Shenzhen, Peoples R China
[7] Capital Med Univ, Beijing Tiantan Hosp, Dept Cardiol & Macrovasc Dis, Beijing, Peoples R China
基金
国家重点研发计划;
关键词
Bioresorbable scaffold; Nitrided iron bioresorbable coronary scaffold; Preclinical study; Completely bioresorbable; ABSORBABLE METAL SCAFFOLD; SUSTAINED SAFETY; BIOSOLVE-II; STENT; BIOCOMPATIBILITY; PERFORMANCE; THROMBOSIS; OUTCOMES;
D O I
10.1016/j.bioactmat.2022.01.005
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This study aimed to investigate the long-term biocompatibility, safety, and degradation of the ultrathin nitrided iron bioresorbable scaffold (BRS) in vivo, encompassing the whole process of bioresorption in porcine coronary arteries. Fifty-two nitrided iron scaffolds (strut thickness of 70 mu m) and 28 Vision Co-Cr stents were randomly implanted into coronary arteries of healthy mini-swine. The efficacy and safety of the nitrided iron scaffold were comparable with those of the Vision stentwithin 52 weeks after implantation. In addition, the long-term biocompatibility, safety, and bioresorption of the nitrided iron scaffold were evaluated by coronary angiography, optical coherence tomography, micro-computed tomography, scanning electron microscopy, energy dispersive spectrometry and histopathological evaluations at 4, 12, 26, 52 weeks and even at 7 years after implantation. In particular, a large number of struts were almost completely absorbed in situ at 7 years follow-up, which were first illustrated in this study. The lymphatic drainage pathway might serve as the potential clearance way of iron and its corrosion products.
引用
收藏
页码:496 / 505
页数:10
相关论文
共 32 条
  • [1] 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy
    Ali, Ziad A.
    Serruys, Patrick W.
    Kimura, Takeshi
    Gao, Runlin
    Ellis, Stephen G.
    Kereiakes, Dean J.
    Onuma, Yoshinobu
    Simonton, Charles
    Zhang, Zhen
    Stone, Gregg W.
    [J]. LANCET, 2017, 390 (10096) : 760 - 772
  • [2] [Anonymous], 2016, ISO 10993-6:2016
  • [3] Lymphatic System in Cardiovascular Medicine
    Aspelund, Aleksanteri
    Robciuc, Marius R.
    Karaman, Sinem
    Makinen, Taija
    Alitalo, Kari
    [J]. CIRCULATION RESEARCH, 2016, 118 (03) : 515 - 530
  • [4] Combined Ultrasmall Superparamagnetic Particles of Iron Oxide-Enhanced and Diffusion-weighted Magnetic Resonance Imaging Facilitates Detection of Metastases in Normal-sized Pelvic Lymph Nodes of Patients with Bladder and Prostate Cancer
    Birkhaeuser, Frederic D.
    Studer, Urs E.
    Froehlich, Johannes M.
    Triantafyllou, Maria
    Bains, Lauren J.
    Petralia, Giuseppe
    Vermathen, Peter
    Fleischmann, Achim
    Thoeny, Harriet C.
    [J]. EUROPEAN UROLOGY, 2013, 64 (06) : 953 - 960
  • [5] Tissue response to partially in vitro predegraded poly-L-lactide implants
    De Jong, WH
    Bergsma, JE
    Robinson, JE
    Bos, RRM
    [J]. BIOMATERIALS, 2005, 26 (14) : 1781 - 1791
  • [6] Haude M, 2017, EUROINTERVENTION, V13, P432, DOI [10.4244/EIJ.D.17.00254, 10.4244/EIJ-D-17-00254]
  • [7] Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
    Haude, Michael
    Ince, Huseyin
    Abizaid, Alexandre
    Toelg, Ralph
    Lemos, Pedro Alves
    von Birgelen, Clemens
    Christiansen, Evald Hoj
    Wijns, William
    Neumann, Franz-Josef
    Kaiser, Christoph
    Eeckhout, Eric
    Lim, Soo Teik
    Escaned, Javier
    Onuma, Yoshinobu
    Garcia-Garcia, Hector M.
    Waksman, Ron
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (35) : 2701 - 2709
  • [8] Bioresorbable scaffolds: rationale, current status, challenges, and future
    Iqbal, Javaid
    Onuma, Yoshinobu
    Ormiston, John
    Abizaid, Alexandre
    Waksman, Ron
    Serruys, Patrick
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (12) : 765 - +
  • [9] Fully bioresorbable vascular scaffolds: lessons learned and future directions
    Jinnouchi, Hiroyuki
    Torii, Sho
    Sakamoto, Atsushi
    Kolodgie, Frank D.
    Virmani, Renu
    Finn, Aloke V.
    [J]. NATURE REVIEWS CARDIOLOGY, 2019, 16 (05) : 286 - 304
  • [10] Long-Term Efficacy of Biodegradable Metal-Polymer Composite Stents After the First and the Second Implantations into Porcine Coronary Arteries
    Li, Xin
    Zhang, Wanqian
    Lin, Wenjiao
    Qiu, Hong
    Qi, Yongli
    Ma, Xun
    Qi, Haiping
    He, Yao
    Zhang, Hongjie
    Qian, Jie
    Zhang, Gui
    Gao, Runlin
    Zhang, Deyuan
    Ding, Jiandong
    [J]. ACS APPLIED MATERIALS & INTERFACES, 2020, 12 (13) : 15703 - 15715